Yvonne Perlberg
Direttore/Membro del Consiglio presso EnGeneIC Pty Ltd.
Posizioni attive di Yvonne Perlberg
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
EnGeneIC Pty Ltd.
 EnGeneIC Pty Ltd. BiotechnologyHealth Technology EnGeneIC Pty Ltd. develops and commercializes novel concepts for the targeted delivery of drugs and other therapeutic molecules used in the treatment of cancer. It offers targeted drug delivery, gene silencing, canine cancers and principal characteristics technology solutions. The company was founded by Jennifer A. MacDiarmid and Himanshu Brahmbhatt in 2001 and is headquartered in Sydney, Australia. | Direttore/Membro del Consiglio | 25/01/2016 | - |
Storia della carriera di Yvonne Perlberg
Formazione di Yvonne Perlberg
| Indiana University | Undergraduate Degree |
| Central Michigan University | Graduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 3 |
| Australia | 2 |
Posizioni
| Director/Board Member | 1 |
| Undergraduate Degree | 1 |
| Graduate Degree | 1 |
Settori
| Consumer Services | 3 |
| Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 1 |
|---|---|
EnGeneIC Pty Ltd.
EnGeneIC Pty Ltd. BiotechnologyHealth Technology EnGeneIC Pty Ltd. develops and commercializes novel concepts for the targeted delivery of drugs and other therapeutic molecules used in the treatment of cancer. It offers targeted drug delivery, gene silencing, canine cancers and principal characteristics technology solutions. The company was founded by Jennifer A. MacDiarmid and Himanshu Brahmbhatt in 2001 and is headquartered in Sydney, Australia. | Health Technology |
- Borsa valori
- Insiders
- Yvonne Perlberg
- Esperienza
